These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1870637

  • 21. The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening.
    Hauser E, Toifl K, Mad A, Bittner R.
    Wien Klin Wochenschr; 1993; 105(15):433-6. PubMed ID: 8104369
    [Abstract] [Full Text] [Related]

  • 22. Early prednisone treatment in Duchenne muscular dystrophy.
    Merlini L, Cicognani A, Malaspina E, Gennari M, Gnudi S, Talim B, Franzoni E.
    Muscle Nerve; 2003 Feb; 27(2):222-7. PubMed ID: 12548530
    [Abstract] [Full Text] [Related]

  • 23. Neuropsychological impairment in Duchenne muscular dystrophy.
    Sollee ND, Latham EE, Kindlon DJ, Bresnan MJ.
    J Clin Exp Neuropsychol; 1985 Oct; 7(5):486-96. PubMed ID: 4066905
    [Abstract] [Full Text] [Related]

  • 24. EMG computerized analysis of localized fatigue in Duchenne muscular dystrophy.
    Frascarelli M, Rocchi L, Feola I.
    Muscle Nerve; 1988 Jul; 11(7):757-61. PubMed ID: 3043217
    [Abstract] [Full Text] [Related]

  • 25. Scoliosis associated with Duchenne muscular dystrophy.
    Lord J, Behrman B, Varzos N, Cooper D, Lieberman JS, Fowler WM.
    Arch Phys Med Rehabil; 1990 Jan; 71(1):13-7. PubMed ID: 2297303
    [Abstract] [Full Text] [Related]

  • 26. Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study.
    Mavrogeni S, Papavasiliou A, Douskou M, Kolovou G, Papadopoulou E, Cokkinos DV.
    Eur J Paediatr Neurol; 2009 Jan; 13(1):34-40. PubMed ID: 18406648
    [Abstract] [Full Text] [Related]

  • 27. [3H]nitrendipine receptors as markers of a class of putative voltage-sensitive Ca2+ channels in normal human skeletal muscle and in muscle from Duchenne muscular dystrophy patients.
    Desnuelle C, Renaud JF, Delpont E, Serratrice G, Lazdunski M.
    Muscle Nerve; 1986 Feb; 9(2):148-51. PubMed ID: 2419753
    [Abstract] [Full Text] [Related]

  • 28. Developmental progress in Duchenne muscular dystrophy: lessons for earlier detection.
    Parsons EP, Clarke AJ, Bradley DM.
    Eur J Paediatr Neurol; 2004 Feb; 8(3):145-53. PubMed ID: 15120686
    [Abstract] [Full Text] [Related]

  • 29. Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network.
    Connolly AM, Florence JM, Cradock MM, Malkus EC, Schierbecker JR, Siener CA, Wulf CO, Anand P, Golumbek PT, Zaidman CM, Philip Miller J, Lowes LP, Alfano LN, Viollet-Callendret L, Flanigan KM, Mendell JR, McDonald CM, Goude E, Johnson L, Nicorici A, Karachunski PI, Day JW, Dalton JC, Farber JM, Buser KK, Darras BT, Kang PB, Riley SO, Shriber E, Parad R, Bushby K, Eagle M, MDA DMD Clinical Research Network.
    Neuromuscul Disord; 2013 Jul; 23(7):529-39. PubMed ID: 23726376
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Relation between height and clinical course in Duchenne muscular dystrophy.
    Zatz M, Rapaport D, Vainzof M, Rocha JM, Pavanello Rde C, Colletto GM, Peres CA.
    Am J Med Genet; 1988 Feb; 29(2):405-10. PubMed ID: 3354613
    [Abstract] [Full Text] [Related]

  • 32. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
    Biggar WD, Politano L, Harris VA, Passamano L, Vajsar J, Alman B, Palladino A, Comi LI, Nigro G.
    Neuromuscul Disord; 2004 Sep; 14(8-9):476-82. PubMed ID: 15336688
    [Abstract] [Full Text] [Related]

  • 33. Assisted bicycle training delays functional deterioration in boys with Duchenne muscular dystrophy: the randomized controlled trial "no use is disuse".
    Jansen M, van Alfen N, Geurts AC, de Groot IJ.
    Neurorehabil Neural Repair; 2013 Sep; 27(9):816-27. PubMed ID: 23884013
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Duchenne muscular dystrophy. Review of 37 cases].
    Pascual Pascual SI, López Terradas JM, Pascual Castroviejo I.
    An Esp Pediatr; 1982 Oct; 17(4):294-301. PubMed ID: 7158879
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy.
    Fenichel GM, Florence JM, Pestronk A, Mendell JR, Moxley RT, Griggs RC, Brooke MH, Miller JP, Robison J, King W.
    Neurology; 1991 Dec; 41(12):1874-7. PubMed ID: 1745340
    [Abstract] [Full Text] [Related]

  • 38. Early diagnosis and secondary prevention of Duchenne muscular dystrophy.
    Smith RA, Sibert JR, Wallace SJ, Harper PS.
    Arch Dis Child; 1989 Jun; 64(6):787-90. PubMed ID: 2476078
    [Abstract] [Full Text] [Related]

  • 39. [Myometric evaluation of patients with Duchenne muscular dystrophy].
    Araújo AP, Duro LA, Araújo AQ, Penque GM.
    Arq Neuropsiquiatr; 1995 Jun; 53(2):233-7. PubMed ID: 7487529
    [Abstract] [Full Text] [Related]

  • 40. [The strength and functional performance of patients with Duchenne muscular dystrophy based on natural history].
    Lue YJ, Jong YJ, Lin YT, Chen SS.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):597-604. PubMed ID: 1296040
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.